Treatment of chronic spontaneous urticaria with benralizumab: Report of primary endpoint per‐protocol analysis and exploratory endpoints
Jonathan A. Bernstein, Umesh Singh, Marepalli B. Rao, Karen Berendts, Xiang Zhang, Diya F. Mutasim
Abstract
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Topics & Concepts
BenralizumabClinical endpointProtocol (science)MedicineInformation retrievalImmunologyInternal medicineComputer scienceAlternative medicineClinical trialPathologyMepolizumabAsthmaEosinophilUrticaria and Related ConditionsAutoimmune Bullous Skin DiseasesCoagulation, Bradykinin, Polyphosphates, and Angioedema